Raman Spectroscopy Reveals That Biochemical Composition of Breast Microcalcifications Correlates with Histopathologic Features.
Biomarkers
/ analysis
Biopsy
Breast
/ chemistry
Breast Carcinoma In Situ
/ chemistry
Breast Diseases
/ diagnosis
Breast Neoplasms
/ chemistry
Calcinosis
/ diagnosis
Calcium Phosphates
/ analysis
Carbonates
/ analysis
Female
Humans
Phosphates
/ analysis
Sensitivity and Specificity
Spectrum Analysis, Raman
/ methods
Journal
Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R
Informations de publication
Date de publication:
15 04 2020
15 04 2020
Historique:
received:
13
10
2019
revised:
28
12
2019
accepted:
21
02
2020
pubmed:
26
2
2020
medline:
21
10
2020
entrez:
26
2
2020
Statut:
ppublish
Résumé
Breast microcalcifications are a common mammographic finding. Microcalcifications are considered suspicious signs of breast cancer and a breast biopsy is required, however, cancer is diagnosed in only a few patients. Reducing unnecessary biopsies and rapid characterization of breast microcalcifications are unmet clinical needs. In this study, 473 microcalcifications detected on breast biopsy specimens from 56 patients were characterized entirely by Raman mapping and confirmed by X-ray scattering. Microcalcifications from malignant samples were generally more homogeneous, more crystalline, and characterized by a less substituted crystal lattice compared with benign samples. There were significant differences in Raman features corresponding to the phosphate and carbonate bands between the benign and malignant groups. In addition to the heterogeneous composition, the presence of whitlockite specifically emerged as marker of benignity in benign microcalcifications. The whole Raman signature of each microcalcification was then used to build a classification model that distinguishes microcalcifications according to their overall biochemical composition. After validation, microcalcifications found in benign and malignant samples were correctly recognized with 93.5% sensitivity and 80.6% specificity. Finally, microcalcifications identified in malignant biopsies, but located outside the lesion, reported malignant features in 65% of
Identifiants
pubmed: 32094303
pii: 0008-5472.CAN-19-3204
doi: 10.1158/0008-5472.CAN-19-3204
doi:
Substances chimiques
Biomarkers
0
Calcium Phosphates
0
Carbonates
0
Phosphates
0
whitlockite
14358-97-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1762-1772Informations de copyright
©2020 American Association for Cancer Research.